Research advances of novel biologic therapeutic agents for lupus nephritis
Lupus nephritis (LN) is a common and serious complication of systemic lupus erythematosus (SLE). Current treatment of LN is based largely upon hormones and immunosuppressants associated with such adverse effects as easy relapse and easy infection. In recent years, researchers have identified a varie...
Saved in:
Main Authors: | Ruo-xi Li (Author), Zhi-min Wang (Author) |
---|---|
Format: | Book |
Published: |
Editorial Department of Journal of Clinical Nephrology,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research advances in targeted therapy of lupus nephritis
by: Gui-qing Tian, et al.
Published: (2024) -
Roles of macrophages in lupus nephritis
by: Yaqian Cheng, et al.
Published: (2024) -
Hidden face of lupus nephritis exposed: Isolated tubulointerstitial lupus nephritis
by: Muhammed Mubarak
Published: (2013) -
Stability of novel urinary biomarkers used for lupus nephritis
by: Ellen M. Cody, et al.
Published: (2022) -
Tubulointerstitial lupus nephritis
by: Ala Ali, et al.
Published: (2013)